The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
GULF TIME
Dr Sulaiman Al Habib Hospital in Dubai is proud to announce a significant achievement in oncology with the successful treatment of a complex liver cancer case involving a 46-year-old patient. This milestone reflects the hospital’s commitment to providing personalized, multi-step oncology care through advanced systemic therapies, innovative interventions, and precision surgery.
The patient was diagnosed with an advanced liver tumor invading the diaphragm and located near the right hepatic vein. To address this challenge, a multidisciplinary oncology team, led by Dr Ali Chamseddine, developed an individualized treatment plan to reduce the tumor effectively while ensuring the safe execution of the surgical resection. This strategy combined systemic therapies, localized interventions, and advanced surgical techniques.
The treatment plan included three key components: systemic immunotherapy to enhance the body’s immune response against cancer cells, localized Y90 radioembolization to precisely target the tumor, and advanced surgery to remove the tumor after significant shrinkage. Dr Mohammad Wehbe, a senior oncological surgeon and New York University graduate, conducted the surgery.
Dr Chamseddine emphasized, “This case exemplifies the power of combining systemic, local, and surgical interventions into a highly personalized, patient-centered treatment plan. It highlights the exceptional quality of oncology care at our hospital and our commitment to high standards of care.”
The results were remarkable. The patient experienced significant tumor shrinkage, enabling safe surgical removal. Tumor marker levels decreased dramatically, indicating a strong response to the treatment regimen. The patient is now recovering well, with an optimistic outlook, reflecting the success of this carefully coordinated step-by-step approach.
This achievement highlights the capabilities of the newly established Oncology Department at Dr Sulaiman Al Habib Hospital. The department offers a comprehensive range of advanced cancer treatments and services. With state-of-the-art technology, it provides personalized chemotherapy, immunotherapy, targeted therapies, locoregional treatments, and complex surgical interventions.
Dr Chamseddine, who leads the oncology department, is a renowned French medical oncologist with dual board certifications in medical oncology and clinical hematology. He trained internationally at the prestigious Gustave Roussy Cancer Campus in France and MD Anderson Cancer Center in the USA. With over 12 years of experience, Dr Chamseddine specializes in precision oncology and has extensive expertise in managing gastrointestinal, breast, genitourinary, and lung cancers.
Dr Chamseddine concluded, “These results demonstrate our commitment to advancing cancer care in the UAE. By integrating the latest medical technologies with a holistic, patient-centered plan, we offer hope and improved outcomes to patients facing even the most challenging diagnoses.”
Dr Sulaiman Al Habib Hospital in Dubai continues to redefine excellence in oncology care, offering patients access to advanced treatments and a dedicated team of experts. The hospital remains committed to pioneering innovative approaches that improve cancer patients’ survival rates and quality of life across the region.